Clinical Trials Logo

Clinical Trial Summary

Step-down approach and late follicular phase progesterone level


Clinical Trial Description

The study will be performed using the stimulation medication Gonal-F which is a recombinant FSH-preparation. Due to application as pen-device, it allows reduction of the stimulation dosage in steps of 12.5IU.

It is important to evaluate the dynamics of progesterone-rise after final oocyte maturation, as this dynamic might also have an influence on the receptivity of the endometrium. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03356964
Study type Interventional
Source IVI Middle East Fertility Clinic
Contact
Status Completed
Phase Early Phase 1
Start date November 23, 2017
Completion date August 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT03519776 - Variation of Progesterone in IVF Cycles
Recruiting NCT06379113 - GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients Phase 2/Phase 3
Recruiting NCT06390904 - GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients Phase 2/Phase 3
Recruiting NCT05316935 - GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients Phase 2/Phase 3
Completed NCT03930212 - Progesterone Supplementation in Threatened Abortion Phase 4
Completed NCT05062135 - Progesterone Action on Endometrium of PCOS N/A